Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 3

1(12.5%)

8Total

N/A(7)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07546344Not ApplicableNot Yet Recruiting

Peer-led Service Delivery Model for Pregnant and Lactating Adolescent Girls and Young Women in Zimbabwe

Role: collaborator

NCT04381936Phase 3Recruiting

Randomised Evaluation of COVID-19 Therapy

Role: collaborator

NCT07070635Not ApplicableRecruiting

Abertay Tea for Cardiovascular Health During Menopause

Role: collaborator

NCT06801691Not ApplicableRecruiting

The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe

Role: collaborator

NCT06769009Not ApplicableRecruiting

EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe

Role: collaborator

NCT06040359Not ApplicableCompleted

Pilot Evaluation of the Thriving Mamas Programme

Role: collaborator

NCT06014554Not ApplicableRecruiting

Structured Tailored Rehabilitation After Hip Fragility Fracture

Role: collaborator

NCT05212766Unknown

Role of the Oral Microbiome & Mucosal Immunity in COVID-19 Disease

Role: collaborator

NCT05952336Unknown

Transmission of Respiratory Viruses in Households in The Gambia: a Longitudinal Cohort Study (TransVIR)

Role: collaborator

NCT03209258Not ApplicableCompleted

The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial

Role: collaborator

All 10 trials loaded